聚乙二醇化
天冬酰胺酶
PEG比率
天冬酰胺
化学
聚乙二醇
酶
重组DNA
部分
生物化学
药物输送
生物物理学
组合化学
立体化学
生物
有机化学
财务
白血病
经济
基因
遗传学
淋巴细胞白血病
作者
R. Sindhu,H. Pradeep,H. K. Manonmani
出处
期刊:Medicinal Chemistry
[Bentham Science Publishers]
日期:2019-02-07
卷期号:15 (6): 705-714
被引量:4
标识
DOI:10.2174/1573406415666190206232816
摘要
L-asparaginase (L-ASN) is an anti-cancer enzyme therapeutic drug that exerts cytotoxicity via inhibition of protein synthesis through depletion of L-asparagine in the tumor microenvironment. The therapeutic performance of the native drug is partial due to the associated instability, reduced half-life and immunogenic complications.In this study, we attempted the modification of recombinant L-asparaginase with PEG and an integrated computational strategy to probe the PEGylation in the protein to understand the biological stability/activity imparted by PEG.In vitro PEGylation of recombinant L-ASN was carried out and further evaluated in silico.PEGylation enhanced thermal and pH activities with extended serum half-life and resistance to proteases compared to the native enzyme. The molecular dynamics analysis revealed intricate interactions required in the coupling of PEG to L-asparaginase to bestow stronger binding affinity of L-asparagine moiety towards L-asparaginase. PEG-asparagine complex ensured stable conformation over both the native protein and asparagine-protein complex thus elucidating the PEG-induced stable conformation in the protein. PEG mechanistically stabilized L-asparaginase through inducing pocket modification at the receptor to adapt to the cavity.The study provides the rationale of PEGylation in imparting the stability towards Lasparaginase which would expand the potential application of L-asparaginase enzyme for the effective treatment of cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI